Skip to main content
. 2021 Jun 2;13(11):2762. doi: 10.3390/cancers13112762

Figure 2.

Figure 2

Clusterization of serum metabolomic fingerprints. Discrimination between patients free from eCRC disease relapse (light blue, dots, n = 65) and patients with mCRC (red dots, n = 75) using the PCA-CA-kNN analysis. Score plot of the first two principal components (A) NOESY1D; (B) CPMG; (C) Diffusion.